{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:10:13Z","timestamp":1761516613932,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.4158\/ep-2019-0246","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T17:09:52Z","timestamp":1565802592000},"page":"1279-1285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Increased Serum Calcitonin in Sporadic Primary Hyperparathyroidism is an Uncommon Occurrence"],"prefix":"10.1016","volume":"25","author":[{"given":"Elena","family":"Castellano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Latina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Gennaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Boriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Borretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0246_bb0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"key":"10.4158\/EP-2019-0246_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.4158\/EP-2019-0246_bb0020","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.beem.2018.09.010","article-title":"Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-jaw tumour, familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism","volume":"32","author":"Eller-Vainicher","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0246_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00000441-198007000-00002","article-title":"Limited calcitonin reserve in hyperparathyroidism","volume":"280","author":"Becker","year":"1980","journal-title":"Am J Med Sci"},{"key":"10.4158\/EP-2019-0246_bb0030","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/jcem-63-3-785","article-title":"Plasma calcitonin in primary hyperparathyroidism: failure of C-cell response to sustained hypercalcemia","volume":"63","author":"Tiegs","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0246_bb0035","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1055\/s-0029-1210708","article-title":"The effect of high parathyroid hormone concentration on calcitonin in patients with primary hyperparathyroidism","volume":"90","author":"K\u00fcbler","year":"1987","journal-title":"Exp Clin Endocrinol"},{"key":"10.4158\/EP-2019-0246_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jcem-49-2-223","article-title":"Calcitonin secretion in primary hyperparathyroidism","volume":"49","author":"Parthemore","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0246_bb0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2265.1981.tb02751.x","article-title":"Calcitonin secretion and bone disease severity in hypercalcaemic hyperparathyroidism","volume":"15","author":"Mazzuoli","year":"1981","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2019-0246_bb0050","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000308170","article-title":"Could primary hyperparathyroidism-related hypercalcemia induce hypercalcitoninemia?","volume":"73","author":"Conte-Devolx","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"10.4158\/EP-2019-0246_bb0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000180309","article-title":"Basal and stimulated calcitonin secretion in primary hyperparathyroidism before and after parathyroidectomy","volume":"23","author":"Tabolli","year":"1986","journal-title":"Horm Res"},{"key":"10.4158\/EP-2019-0246_bb0060","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2 suppl 1","key":"10.4158\/EP-2019-0246_bb0065","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.4158\/EP-2019-0246_bb0070","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/endo-70-5-638","article-title":"Evidence for calcitonin\u2013a new hormone from the parathyroid that lowers blood calcium","volume":"70","author":"Copp","year":"1962","journal-title":"Endocrinology"},{"key":"10.4158\/EP-2019-0246_bb0075","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"137","article-title":"Calcitonin","author":"Deftos","year":"2003"},{"key":"10.4158\/EP-2019-0246_bb0080","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1210\/en.2005-1616","article-title":"Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation","volume":"147","author":"Woodrow","year":"2006","journal-title":"Endocrinology"},{"key":"10.4158\/EP-2019-0246_bb0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1432-1033.1984.tb07996.x","article-title":"Rapid increase of calcitonin-specific mRNA after acute hypercalcemia","volume":"139","author":"Segond","year":"1984","journal-title":"Eur J Biochem"},{"key":"10.4158\/EP-2019-0246_bb0090","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2362.2002.01052.x","article-title":"Rate-dependency of calcitonin secretion in response to increased plasma Ca 2+","volume":"32","author":"Wang","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.4158\/EP-2019-0246_bb0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1359\/JBMR.051210","article-title":"Dissimilar PTH, gastrin, and calcitonin responses to oral calcium and peptones in hypocalciuric hypercalcemia, primary hyperparathyroidism, and normal subjects: a useful tool for differential diagnosis","volume":"21","author":"Bevilacqua","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP-2019-0246_bb0100","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1373\/clinchem.2003.026963","article-title":"Reference intervals for serum calcitonin in men, women, and children","volume":"50","author":"Basuyau","year":"2004","journal-title":"Clin Chem"},{"key":"10.4158\/EP-2019-0246_bb0105","first-page":"723","article-title":"Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis","volume":"26","author":"Schuetz","year":"2006","journal-title":"Anticancer Res"},{"key":"10.4158\/EP-2019-0246_bb0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/jc.2003-030709","article-title":"Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects","volume":"89","author":"Karanikas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0246_bb0115","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4158\/EP-2018-0016","article-title":"Unknown and already known thyroid abnormalities in primary hyperparathyroidism","volume":"24","author":"Latina","year":"2018","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2019-0246_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1472-6890-13-27","article-title":"Investigation of factors potentially influencing calcitonin levels in the screening and follow-up for medullary thyroid carcinoma: a cautionary note","volume":"13","author":"Guesgen","year":"2013","journal-title":"BMC Clin Pathol"},{"key":"10.4158\/EP-2019-0246_bb0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2265.2007.02747.x","article-title":"Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery","volume":"66","author":"Schott","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2019-0246_bb0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/eje.0.1320075","article-title":"Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis","volume":"132","author":"Niccoli","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2019-0246_bb0135","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1172\/JCI109342","article-title":"Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism","volume":"63","author":"Lambert","year":"1979","journal-title":"J Clin Invest"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20351259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20351259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:05:27Z","timestamp":1761516327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20351259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1530891X20351259"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0246","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Serum Calcitonin in Sporadic Primary Hyperparathyroidism is an Uncommon Occurrence","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}